Objective The present study evaluated the profile of germline mutations present in patients who underwent genetic counseling for risk assessment for breast cancer (BC), ovarian cancer (OC), and endometrial cancer (EC) with a possible hereditary pattern. Methods Medical records of 382 patients who underwent genetic counseling after signing an informed consent form were analyzed. A total of 55.76% of patients (213/382) were symptomatic (personal history of cancer), and 44.24% (169/382) were asymptomatic (absence of the disease). The variables analyzed were age, sex, place of birth, personal or family history of BC, OC, EC, as well as other types of cancer associated with hereditary syndromes. The Human Genome Variation Society (HGVS) nomenclature guidelines were used to name the variants, and their biological significance was determined by comparing 11 databases. Results We identified 53 distinct mutations: 29 pathogenic variants, 13 variants of undetermined significance (VUS), and 11 benign. The most frequent mutations were BRCA1 c.470_471delCT, BRCA1 c.4675 + 1G > T, and BRCA2 c.2T> G. Furthermore, 21 variants appear to have been described for the first time in Brazil. In addition to BRCA1/2 mutations, variants in other genes related to hereditary syndromes that predispose to gynecological cancers were found. Conclusion This study allowed a deeper understanding of the main mutations identified in families in the state of Minas Gerais and demonstrates the need to assess the family history of non-gynecological cancer for risk assessment of BC, OC, and EC. Moreover, it is an effort that contributes to population studies to evaluate the cancer risk mutation profile in Brazil.
Objective: To describe the epidemiological data of women with breast cancer at a referral center in oncology in the northern region of Brazil. Methods: This is a retrospective cohort study. The study population consists of patients who were diagnosed with in situ or invasive BC (invasive carcinoma of no special type (ICNST) and invasive […] Abstract Objective: To describe the epidemiological data of women with breast cancer at a referral center in oncology in the northern region of Brazil. Methods: This is a retrospective cohort study. The study population consists of patients who were diagnosed with in situ or invasive BC (invasive carcinoma of no special type (ICNST) and invasive […]
O câncer epitelial de ovário e o câncer de endométrio apresentam uma alta taxa de mortalidade entre mulheres de todas as idades. Tanto na avaliação diagnóstica quanto de risco para essas neoplasias malignas deve-se considerar a possibilidade de uma etiologia hereditária, a qual pode ser identificável através de testes genéticos. O câncer de ovário de origem epitelial é um dos cânceres com maior relação com a hereditariedade, até 25% dos casos apresentam mutações germinativas identificáveis. Síndromes e/ou genes de alto risco para o câncer ginecológico como a Síndrome de predisposição ao câncer de mama e ovários associadas aos genes BRCA1/2, síndrome de Lynch aos genes MMR, Síndrome de Cowden ao gene PTEN, devem ser reconhecidas e podem ter impacto relevante para guiar condutas cirúrgicas e oncológicas. Entretanto, a abordagem faz-se através do processo do aconselhamento genético que é um processo dinâmico e que pode ser decisivo na avaliação do paciente oncológico e familiares em risco para câncer.
Highlights ■ Family identified with recurrent colorectal cancer, suggestive of Lynch syndrome. ■ A new variant was detected, NM_000251.3(MSH2):c.1894_1898del (p.Ile633Lysfs*9). ■ The variant causes a frameshift mutation leading to a premature stop codon, suggesting pathogenicity. ■ Using bioinformatics tools, we investigated possible escape mechanisms, such as the presence of isoforms without the mutated exon. ■ Location of the variant suggests that it causes non-sense mediated decay, which is reinforced by immunohistochemistry findings showing absence of MSH2 protein expression. ■ Detailed